Nutrition Business Journal
Introducing the Future of Gut HealthCobiotics

Introducing the Future of Gut HealthCobiotics

Dean Stull, PhD, is president and CEOEO of NuMe Health, a developer of cobiotic supplements designed to alter gut bacteria for the management of chronic health conditions. Stull is an expert in botanically-derived pharmaceuticals, and has held leadership roles at Pyxant Laboratories, Efficas, Hauser and Paxis Pharmaceuticals. NBJ spoke with Stull from our offices in Boulder, Colorado.

nbj: One thing people often forget about pharmaceuticals is that many originally come from natural sources.
Dean Stull: In the last 100 years, what are the two most significant drugs? Penicillin was the first antibiotic and it was discovered in 1937, commercialized in 1947, synthesized in 1957. It was first isolated from mold found on an orange rind. The second most significant pharmaceutical of the last 100 years is aspirin. Where did it come from? Aspirin used to be

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.